Page last updated: 2024-08-24

pyrrolidine dithiocarbamate and Inflammatory Bowel Diseases

pyrrolidine dithiocarbamate has been researched along with Inflammatory Bowel Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kamiie, K; Kidachi, Y; Lohning, A; Ryoyama, K; Sasaki, K; Yamaguchi, H1

Other Studies

1 other study(ies) available for pyrrolidine dithiocarbamate and Inflammatory Bowel Diseases

ArticleYear
6-(methylsulfinyl)hexyl isothiocyanate (6-MITC) from Wasabia japonica alleviates inflammatory bowel disease (IBD) by potential inhibition of glycogen synthase kinase 3 beta (GSK-3β).
    European journal of medicinal chemistry, 2021, Apr-15, Volume: 216

    Topics: Animals; Anti-Inflammatory Agents; Cell Line; Dextran Sulfate; Down-Regulation; Female; Glycogen Synthase Kinase 3 beta; Humans; Inflammatory Bowel Diseases; Interleukin-6; Isothiocyanates; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred BALB C; NF-kappa B; Nitric Oxide Synthase Type II; Signal Transduction; Up-Regulation; Wasabia

2021